Your browser doesn't support javascript.
loading
Review of the current use and evaluation of cell substrates for producing biologicals in selected countries.
Kang, Hye-Na; Xu, Miao; Rodríguez, Violeta Pérez; Mefed, Kirill; Hanada, Kentaro; Ahn, Kwang-Soo; Gangakhedkar, Shri Jayant; Pakzad, Saeed Reza; Prawahju, Elizabeth Ika; Lee, Naery; Phumiamorn, Supaporn; Nemec, Martin; Meng, Shufang; Knezevic, Ivana.
Afiliación
  • Kang HN; World Health Organization, Department of Essential Medicines and Health Products, Avenue Appia 20, CH-1211 Geneva, Switzerland. Electronic address: kangh@who.int.
  • Xu M; Institute for Biological Product Control, National Institutes for Food and Drug Control, People's Republic of China.
  • Rodríguez VP; Centro para el Control Estatal de la Calidad de los Medicamentos, Cuba.
  • Mefed K; Scientific Center for Expertise of Pharmaceuticals for Medical Use, Ministry of Public Health, Russia.
  • Hanada K; Department of Biochemistry & Cell Biology, National Institute of Infectious Diseases, Japan.
  • Ahn KS; National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Korea.
  • Gangakhedkar SJ; Central Drugs Standard Control Organization, India.
  • Pakzad SR; Vaccine Potency Section, Food and Drug Control Laboratories & Research Center, Islamic Republic of Iran.
  • Prawahju EI; National Quality Control Laboratory of Drug and Food, National Agency of Drug and Food Control, Indonesia.
  • Lee N; National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Korea.
  • Phumiamorn S; Institute of Biological Products, Ministry of Public Health, Thailand.
  • Nemec M; Biologics and Genetic Therapies Directorate, Health Canada, Canada.
  • Meng S; Institute for Biological Product Control, National Institutes for Food and Drug Control, People's Republic of China.
  • Knezevic I; World Health Organization, Department of Essential Medicines and Health Products, Avenue Appia 20, CH-1211 Geneva, Switzerland.
Biologicals ; 43(3): 153-7, 2015 May.
Article en En | MEDLINE | ID: mdl-25707711
ABSTRACT
In 2010, the WHO guidance document for the evaluation of cell substrates for producing biologicals was replaced with updated recommendations and in May 2013 an implementation workshop on the new recommendations was held in Beijing, China. As part of this workshop, a survey of the use and evaluation of cell substrates for producing biologicals was undertaken and the information obtained was updated in June 2014. The purpose of survey was to capture the status of national requirements related to cell substrates in various countries with particular emphasis on whether or not the updated WHO recommendations had been, or were to be, incorporated into national requirements. This paper reports the outcome of the survey and is based on information provided by regulators in eleven countries. Since the publication of the updated WHO recommendations, several activities such as the implementation workshop and publications have been undertaken by the WHO. The aim of these activities, including the publication of this article, is to contribute to the implementation of WHO recommendations so as to reduce regulatory gaps between national requirements and globally agreed expectations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal Asunto principal: Biofarmacia Límite: Humans Idioma: En Revista: Biologicals Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal Asunto principal: Biofarmacia Límite: Humans Idioma: En Revista: Biologicals Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2015 Tipo del documento: Article
...